COG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.523000E-01
Normal-vs-Stage2
9.394000E-01
Normal-vs-Stage3
7.268100E-02
Normal-vs-Stage4
6.697600E-01
Stage1-vs-Stage2
1.144830E-01
Stage1-vs-Stage3
6.042700E-03
Stage1-vs-Stage4
2.905200E-01
Stage2-vs-Stage3
4.029600E-02
Stage2-vs-Stage4
7.707600E-01
Stage3-vs-Stage4
8.383400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.772600E-01
Normal-vs-AfricanAmerican
7.408600E-01
Normal-vs-Asian
9.470800E-01
Caucasian-vs-AfricanAmerican
8.357800E-01
Caucasian-vs-Asian
8.752200E-01
AfricanAmerican-vs-Asian
7.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.060800E-01
Normal-vs-Female
9.300600E-01
Male-vs-Female
6.870000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.705200E-01
Normal-vs-Age(41-60Yrs)
6.747000E-01
Normal-vs-Age(61-80Yrs)
9.746000E-01
Normal-vs-Age(81-100Yrs)
9.705600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.377000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.627000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.369200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.792830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.684000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.978000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.907600E-01
Normal-vs-Daily Drinker
5.722600E-01
Normal-vs-Weekly Drinker
6.772400E-01
Normal-vs-Occasional Drinker
4.393600E-01
Normal-vs-Social Drinker
5.523400E-01
Non Drinker-vs-Daily Drinker
4.937400E-01
Non Drinker-vs-Weekly Drinker
6.654400E-01
Non Drinker-vs-Occasional Drinker
4.215900E-02
Non Drinker-vs-Social Drinker
1.223580E-01
Daily Drinker-vs-Weekly Drinker
9.023000E-01
Daily Drinker-vs-Occasional Drinker
2.221800E-02
Daily Drinker-vs-Social Drinker
6.644000E-02
Weekly Drinker-vs-Occasional Drinker
3.639900E-02
Weekly Drinker-vs-Social Drinker
1.039030E-01
Occasional Drinker-vs-Social Drinker
6.233200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.605600E-02
Normal-vs-Grade 2
1.178080E-03
Normal-vs-Grade 3
1.915170E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.670200E-01
Grade 1-vs-Grade 3
2.736200E-01
Grade 1-vs-Grade 4
8.605600E-02
Grade 2-vs-Grade 3
5.240400E-01
Grade 2-vs-Grade 4
1.178080E-03
Grade 3-vs-Grade 4
1.915170E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.514800E-01
Normal-vs-NonDiabetic
8.169400E-01
Diabetic-vs-NonDiabetic
1.140390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.852200E-01
Normal-vs-NoPancreatitis
8.922400E-01
Pancreatitis-vs-NoPancreatitis
4.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.787800E-01
Normal-vs-N1
9.528800E-01
N0-vs-N1
3.442600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.619400E-01
Normal-vs-TP53-NonMutant
5.544400E-01
TP53-Mutant-vs-TP53-NonMutant
6.400400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
